دورية أكاديمية

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis

التفاصيل البيبلوغرافية
العنوان: CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
المؤلفون: Dunbar A. J., Kim D., Lu M., Farina M., Bowman R. L., Yang J. L., Park Y., Karzai A., Xiao W., Zaroogian Z., O'Connor K., Mowla S., Gobbo F., Verachi P., Martelli F., Sarli G., Xia L., Elmansy N., Kleppe M., Chen Z., Xiao Y., McGovern E., Snyder J., Krishnan A., Hill C., Cordner K., Zouak A., Salama M. E., Yohai J., Tucker E., Chen J., Zhou J., McConnell T., Migliaccio A. R., Koche R., Rampal R., Fan R., Levine R. L., Hoffman R.
المساهمون: Dunbar A.J., Kim D., Lu M., Farina M., Bowman R.L., Yang J.L., Park Y., Karzai A., Xiao W., Zaroogian Z., O'Connor K., Mowla S., Gobbo F., Verachi P., Martelli F., Sarli G., Xia L., Elmansy N., Kleppe M., Chen Z., Xiao Y., McGovern E., Snyder J., Krishnan A., Hill C., Cordner K., Zouak A., Salama M.E., Yohai J., Tucker E., Chen J., Zhou J., McConnell T., Migliaccio A.R., Koche R., Rampal R., Fan R., Levine R.L., Hoffman R.
سنة النشر: 2023
المجموعة: IRIS Università degli Studi di Bologna (CRIS - Current Research Information System)
مصطلحات موضوعية: CXCL8, CXCR2, bone marrow, myelofibrosis
الوصف: Proinflammatory signaling is a hallmark feature of human cancer, including in myeloproliferative neoplasms (MPNs), most notably myelofibrosis (MF). Dysregulated inflammatory signaling contributes to fibrotic progression in MF; however, the individual cytokine mediators elicited by malignant MPN cells to promote collagen-producing fibrosis and disease evolution are yet to be fully elucidated. Previously, we identified a critical role for combined constitutive JAK/STAT and aberrant NF-κB proinflammatory signaling in MF development. Using single-cell transcriptional and cytokine-secretion studies of primary cells from patients with MF and the human MPLW515L (hMPLW515L) murine model of MF, we extend our previous work and delineate the role of CXCL8/CXCR2 signaling in MF pathogenesis and bone marrow fibrosis progression. Hematopoietic stem/progenitor cells from patients with MF are enriched for a CXCL8/CXCR2 gene signature and display enhanced proliferation and fitness in response to an exogenous CXCL8 ligand in vitro. Genetic deletion of Cxcr2 in the hMPLW515L-adoptive transfer model abrogates fibrosis and extends overall survival, and pharmacologic inhibition of the CXCR1/2 pathway improves hematologic parameters, attenuates bone marrow fibrosis, and synergizes with JAK inhibitor therapy. Our mechanistic insights provide a rationale for therapeutic targeting of the CXCL8/CXCR2 pathway among patients with MF.
نوع الوثيقة: article in journal/newspaper
وصف الملف: ELETTRONICO
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36800567; info:eu-repo/semantics/altIdentifier/wos/WOS:001004287400001; volume:141; issue:20; firstpage:2508; lastpage:2519; numberofpages:12; journal:BLOOD; https://hdl.handle.net/11585/940236Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85153103771; https://ashpublications.org/blood/article/141/20/2508/494598/CXCL8-CXCR2-signaling-mediates-bone-marrowTest
DOI: 10.1182/blood.2022015418
الإتاحة: https://doi.org/10.1182/blood.2022015418Test
https://hdl.handle.net/11585/940236Test
https://ashpublications.org/blood/article/141/20/2508/494598/CXCL8-CXCR2-signaling-mediates-bone-marrowTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.AE42793C
قاعدة البيانات: BASE